Andrew von Eschenbach
Director/Board Member presso BAUSCH + LOMB CORPORATION
Patrimonio netto: 595 534 $ in data 31/03/2024
Provenienza dei contatti di primo grado di Andrew von Eschenbach
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland.
27
| Extinct | Pharmaceuticals: Major | 27 |
| Public Company | Medical Specialties | 21 | |
| Holding Company | Biotechnology | 20 | |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD.
19
| Government | General Government | 19 |
Focused Ultrasound Foundation
 Focused Ultrasound Foundation Miscellaneous Commercial ServicesCommercial Services Focused Ultrasound Foundation is an early-sage company, which engages in the provision of non-invasive therapeutic technology. It focuses on cardiovascular, endocrine disorders, gastrointestinal, musculoskeletal, neurological, oncological, urological, and women''s health sectors. The company was founded by Neal F. Kassell and is headquartered in Charlottesville, VA.
19
| Foundation/Endowment | Miscellaneous Commercial Services | 19 |
| Public Company | Miscellaneous Commercial Services | 15 | |
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC.
15
| Holding Company | Pharmaceuticals: Major | 15 |
| Public Company | Medical Specialties | 14 | |
Viamet Pharmaceuticals, Inc.
 Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC.
13
| Subsidiary | Pharmaceuticals: Major | 13 |
| Public Company | Pharmaceuticals: Other | 11 | |
Reagan-udall Foundation
11
| Non-Profit Organization | 11 | |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY.
10
| Subsidiary | Medical Specialties | 10 |
| Subsidiary | Biotechnology | 9 | |
Banyan Biomarkers, Inc.
 Banyan Biomarkers, Inc. Medical/Nursing ServicesHealth Services Banyan Biomarkers, Inc. engages in the commercialization of vitro diagnostic tests for the detection of brain injury and neurological diseases. It develops blood test to accurately and quickly diagnose traumatic brain injury. The company was founded by Nancy Denslow, Ronald L. Hayes, and Kevin Wang in 2002 and is headquartered in San Diego, CA.
8
| Subsidiary | Medical/Nursing Services | 8 |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD.
8
| Government | General Government | 8 |
| Public Company | Biotechnology | 8 | |
Wavebreak Therapeutics Ltd.
 Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Innocrin Pharmaceuticals Holdings LLC
 Innocrin Pharmaceuticals Holdings LLC Medical SpecialtiesHealth Technology Innocrin Pharmaceuticals Holdings LLC discovers and develops oral inhibitors for the treatment of Castration-Resistant Prostate Cancer (CRPC). The company is headquartered in Durham, NC.
6
| Subsidiary | Medical Specialties | 6 |
Innocrin Pharmaceuticals, Inc.
 Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC.
6
| Holding Company | Pharmaceuticals: Major | 6 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD.
6
| Non-Profit Organization | Investment Trusts/Mutual Funds | 6 |
National Comprehensive Cancer Network Foundation
2
| Non-Profit Organization | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Andrew von Eschenbach tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Quintiles Transnational Corp.
 Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member President Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member Corporate Officer/Principal | |
| THE GOLDMAN SACHS GROUP, INC. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
| PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Chairman Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
CSA Medical, Inc.
 CSA Medical, Inc. Medical SpecialtiesHealth Technology CSA Medical, Inc. develops endoscopic cryoablation systems. It provides spray cryotherapy medical device solutions that improve patient outcomes, simplify procedures, and reduce the cost of healthcare. The company was founded by Lloyd Shue, Timothy E. Askew and Frank Majerowicz in 1985 and is headquartered in Lexington, MA. | Medical Specialties | Director/Board Member Director/Board Member | |
| Icahn Capital LP | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| NVN LIQUIDATION, INC. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member | |
Esanex, Inc.
 Esanex, Inc. Pharmaceuticals: MajorHealth Technology Esanex, Inc. manufactures and develops drugs for cancer treatment. Its products include orally active Hsp90 inhibitors. The company was founded in 2011 and is headquartered in Indianapolis, IN. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MALIN CORPORATION PLC | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Chairman Chairman Founder Director/Board Member Chairman Chief Executive Officer Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Graduate Degree | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
| University of Pennsylvania | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
Research Triangle Institute
 Research Triangle Institute Miscellaneous Commercial ServicesCommercial Services Research Triangle Institute is a non-profit organization which provides research and development services. It offers surveys and data collection, statistics and data science, assessment and analysis, program design and implementation, and research technologies and analytical laboratory. The company was founded in 1958 and is headquartered in Research Triangle Park, NC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| New York University | College/University | Director/Board Member Masters Business Admin Doctorate Degree Graduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| University College Dublin | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Hatteras Venture Partners
 Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | Investment Managers | Private Equity Investor Private Equity Investor | |
CEO Roundtable on Cancer, Inc.
 CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services CEO Roundtable on Cancer, Inc. promotes activities to reduce cancer risk, enable early detection, facilitate better access to treatment and hasten the discovery. Its programs include CEO cancer gold standard, life sciences consortium and project data sphere. The company was founded by George H. W. Bush in 2001 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Founder Corporate Officer/Principal | |
| DANA INCORPORATED | Auto Parts: OEM | Director/Board Member Director/Board Member Director/Board Member | |
| Glaxo, Inc. | Chairman Director/Board Member | ||
The Jed Foundation
 The Jed Foundation Miscellaneous Commercial ServicesCommercial Services The Jed Foundation exists to protect emotional health and prevent suicide for nation's teens and young adults. It develops expert resources and create partnerships. The firm educates and equip students, families and communities. The company was founded in 2000 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ALLERGAN PLC | Pharmaceuticals: Major | Chief Executive Officer General Counsel Public Communications Contact Human Resources Officer Compliance Officer | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
TriSalus Operating Life Sciences, Inc.
 TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Chief Executive Officer Director/Board Member | |
| SURO CAPITAL CORP. | Investment Managers | Director/Board Member Director/Board Member | |
| COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| PERRIGO COMPANY PLC | Pharmaceuticals: Major | Public Communications Contact Director/Board Member Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
Brandon Point Industries Ltd.
 Brandon Point Industries Ltd. Medical/Nursing ServicesHealth Services Brandon Point Industries Ltd. operates as a life sciences company. It focuses on healthcare. The company was founded in 2014 by George Kelly Martin and John Oliver Thomas Given and is headquartered in Dublin, Ireland. | Medical/Nursing Services | Founder Director/Board Member Director/Board Member | |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Chairman Director/Board Member | |
Malin Life Sciences Holdings Ltd.
 Malin Life Sciences Holdings Ltd. Financial ConglomeratesFinance Part of Malin Corp. Plc, Malin Life Sciences Holdings Ltd. functions as an investment holding Irish company. The private company is based in Dublin, Ireland. The CEO of the company is George Kelly Martin. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Director/Board Member Director/Board Member | |
Allergan Plc
 Allergan Plc Pharmaceuticals: MajorHealth Technology Allergan Plc is a global pharmaceutical company that develops, manufactures, and markets branded pharmaceutical, device, biologic, surgical, and regenerative medicine products for patients worldwide. The private company is based in Madison, NJ, with operations in approximately 100 countries. The company has a broad portfolio of leading brands and products in various therapeutic categories, including central nervous system, eye care, medical aesthetics, dermatology, gastroenterology, women's health, urology, and anti-infective. Allergan is an industry leader in open science, a model of research and development that focuses on identifying and developing innovative ideas and innovation for better patient care. | Pharmaceuticals: Major | President Human Resources Officer | |
Transition Bio, Inc.
 Transition Bio, Inc. BiotechnologyHealth Technology Transition Bio, Inc. is a company based in Watertown, MA that is developing technologies for biomolecular condensate analysis. The company's proprietary drug discovery platform, CondensomicsTM, utilizes droplet microfluidics and machine learning to map and modulate condensates in molecular detail. The company's goal is to build a drug discovery engine based on the latest advancements in biophysics and artificial intelligence. Transition Bio has been founded by Sarah Teichmann, David A. Weitz, Peter H. St George-Hyslop, and Tuomas Knowles. | Biotechnology | Chairman Director/Board Member | |
| ALKERMES PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Serenus Biotherapeutics, Inc.
 Serenus Biotherapeutics, Inc. Medical DistributorsDistribution Services Serenus Biotherapeutics, Inc. distributes and manufactures pharmaceutical drug products. The company is headquartered in San Francisco, CA. | Medical Distributors | Chairman Founder |
Statistiche
Distribuzione geografica
| Stati Uniti | 40 |
| Irlanda | 8 |
| Regno Unito | 3 |
| Francia | 2 |
| Canada | 2 |
Settori
| Health Technology | 22 |
| Consumer Services | 13 |
| Commercial Services | 7 |
| Finance | 7 |
| Miscellaneous | 2 |
Posizioni
| Director/Board Member | 781 |
| Corporate Officer/Principal | 248 |
| Independent Dir/Board Member | 232 |
| Chairman | 126 |
| Chief Executive Officer | 90 |
Contatti più connessi
| Insiders | |
|---|---|
| Jay Bloom | 56 |
| Robert Alexander Ingram | 43 |
| Franklin Berger | 41 |
| Mark McClellan | 41 |
| Brenton Saunders | 38 |
| Fred Eshelman | 34 |
| Paul Gary Kennedy | 33 |
| David Matlin | 33 |
| Ambrose Bailey | 32 |
| Patrick Kennedy | 30 |
| Hans-Peter Hasler | 28 |
| Douglas Reed | 27 |
| John Niederhuber | 25 |
| Richard de Schutter | 24 |
| Dennis Dougherty | 23 |
- Borsa valori
- Insiders
- Andrew von Eschenbach
- Connessioni Società
